molecularProfile_name,disease_name,therapies,gene_list,etype,significance
STAT5B Overexpression,Melanoma,Multi-subtype Natural Human Leukocyte Interferon Alpha,STAT5B,PREDICTIVE,RESISTANCE
KRAS G12A,Multiple Myeloma,Melphalan,KRAS,PREDICTIVE,RESISTANCE
PIK3CA E545V,Colorectal Cancer,Panitumumab,"NRAS,FBXW7,EGFR,MAP2K1,ERBB2,PIK3CA,BRAF,PTEN,SMAD4,KRAS",PREDICTIVE,RESISTANCE
PIK3CA H1047R,Breast Cancer,Trastuzumab,"ERBB3,ERBB2,PIK3CA,PTEN,BIRC5,ERBB4",PREDICTIVE,RESISTANCE
BRAF V600E,Colorectal Cancer,Bevacizumab,"PIK3CA,BRAF,FOXF1,KRAS,EPHB4",PREDICTIVE,RESISTANCE
KRAS G12D,Lung Cancer,Gefitinib,"KRAS,EGFR",PREDICTIVE,RESISTANCE
KRAS G12D,Lung Cancer,Erlotinib,KRAS,PREDICTIVE,RESISTANCE
EGFR S768N,Lung Non-small Cell Carcinoma,Erlotinib,"NRAS,NRG1,GNAS,EGFR,ERBB2,PIK3CA,BRAF,KRAS",PREDICTIVE,RESISTANCE
RUNX1 Mutation,Acute Myeloid Leukemia,Cytarabine,"WT1,RUNX1",PREDICTIVE,RESISTANCE
BTK C481S,Chronic Lymphocytic Leukemia,Ibrutinib,BTK,PREDICTIVE,RESISTANCE
PTEN Loss,Bladder Carcinoma,Everolimus,PTEN,PREDICTIVE,RESISTANCE
ERCC2 K751Q,Osteosarcoma,Cisplatin,ERCC2,PREDICTIVE,RESISTANCE
SMO Mutation,Basal Cell Carcinoma,Vismodegib,SMO,PREDICTIVE,RESISTANCE
PIK3CA Mutation,Colorectal Cancer,Anti-EGFR Monoclonal Antibody,"PIK3CA,MET",PREDICTIVE,RESISTANCE
BCL2L11 Deletion Polymorphism,Lung Non-small Cell Carcinoma,Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor,BCL2L11,PREDICTIVE,RESISTANCE
BIRC5 Overexpression,Her2-receptor Positive Breast Cancer,Trastuzumab,"ERBB3,ERBB2,PIK3CA,PTEN,BIRC5",PREDICTIVE,RESISTANCE
CDK6 Overexpression,Estrogen-receptor Positive Breast Cancer,Fulvestrant,CDK6,PREDICTIVE,RESISTANCE
EGFR Wildtype,Lung Non-small Cell Carcinoma,Gefitinib,"NRG1,IGF1R,GNAS,EGFR,SMO,PIK3CA,MET,PBK,CRKL,KRAS",PREDICTIVE,RESISTANCE
CD274 Expression,Head And Neck Squamous Cell Carcinoma,Radiation Therapy,CD274,PREDICTIVE,RESISTANCE
SMAD4 Loss-of-function,Colorectal Cancer,Lysine,SMAD4,PREDICTIVE,RESISTANCE
EGFR Exon 19 Deletion,Lung Non-small Cell Carcinoma,Anti-PD1 Monoclonal Antibody,EGFR,PREDICTIVE,RESISTANCE
EGFR Exon 19 Deletion,Lung Non-small Cell Carcinoma,Anti-PD-L1 Monoclonal Antibody,EGFR,PREDICTIVE,RESISTANCE
BCL2 G101A,Chronic Lymphocytic Leukemia/small Lymphocytic Lymphoma,Venetoclax,"TP53,BCL2",PREDICTIVE,RESISTANCE
BCL2 V156D,Chronic Lymphocytic Leukemia,Venetoclax,"PLCG2,TP53,BTK,BCL2",PREDICTIVE,RESISTANCE
CD44 CD44v6,Cervical Cancer,Cisplatin,"PIK3CA,CD44",PREDICTIVE,RESISTANCE
VEGFA Overexpression of VEGF121,Glioblastoma,Bevacizumab,VEGFA,PREDICTIVE,RESISTANCE
AR Overexpression of AR-V9,Prostate Cancer,Abiraterone,AR,PREDICTIVE,RESISTANCE
AR AR-V7,Prostate Cancer,Enzalutamide,AR,PREDICTIVE,RESISTANCE
AR V567es expression,Prostate Cancer,Taxane Compound,AR,PREDICTIVE,RESISTANCE
FLT3 ITD,Acute Myeloid Leukemia,Tretinoin,FLT3,PREDICTIVE,RESISTANCE
CDKN1A EXPRESSION,Colorectal Cancer,Fluorouracil,"ALCAM,PIK3CA,CDKN1A,LGR5,ERCC6,SMAD4,TYMS,DKK1",PREDICTIVE,RESISTANCE
STMN1 EXPRESSION,Endometrial Carcinoma,Paclitaxel,STMN1,PREDICTIVE,RESISTANCE
CCND1 Overexpression,Estrogen-receptor Positive Breast Cancer,Tamoxifen,"AURKA,CCND1",PREDICTIVE,RESISTANCE
KRAS RS61764370,Head And Neck Squamous Cell Carcinoma,Cisplatin,KRAS,PREDICTIVE,RESISTANCE
TYMS Amplification,Lung Adenocarcinoma,Pemetrexed,TYMS,PREDICTIVE,RESISTANCE
DNMT1 EXPRESSION,Gastric Adenocarcinoma,Cisplatin,DNMT1,PREDICTIVE,RESISTANCE
EGFR C797S,Lung Non-small Cell Carcinoma,Osimertinib,EGFR,PREDICTIVE,RESISTANCE
MMP9 SERUM LEVELS,Inflammatory Breast Carcinoma,Bevacizumab,MMP9,PREDICTIVE,RESISTANCE
KRAS Exon 2 Mutation,Colorectal Cancer,Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor,"HRAS,KRAS",PREDICTIVE,RESISTANCE
KIT Amplification,Mucosal Melanoma,Imatinib,KIT,PREDICTIVE,RESISTANCE
AURKA Overexpression,Ovarian Serous Carcinoma,Platinum Compound,AURKA,PREDICTIVE,RESISTANCE
BRCA1 Mutation,Triple-receptor Negative Breast Cancer,Olaparib,BRCA1,PREDICTIVE,RESISTANCE
BRAF V600E,Colorectal Cancer,Oxaliplatin,"ERBB2,PIK3CA,BRAF,FOXC2,KRAS,DKK1",PREDICTIVE,RESISTANCE
TP53 Deleterious Mutation,Leukemia,RG7112,TP53,PREDICTIVE,RESISTANCE
KIT Amplification,Melanoma,Nilotinib,KIT,PREDICTIVE,RESISTANCE
KMT2C Loss,Breast Cancer,Aromatase Inhibitor,"KMT2C,ESR1",PREDICTIVE,RESISTANCE
TERT Promoter Mutation,Thyroid Gland Carcinoma,Iodine I-131,TERT,PREDICTIVE,RESISTANCE
TP53 Mutation,Glioblastoma,Temozolomide,TP53,PREDICTIVE,RESISTANCE
FLT3 F691L,Acute Myeloid Leukemia,Quizartinib,"FGF2,FLT3",PREDICTIVE,RESISTANCE
MS4A1 Mutation,Diffuse Large B-cell Lymphoma,R-CHOP Regimen,MS4A1,PREDICTIVE,RESISTANCE
Chromothripsis Positive,Acute Myeloid Leukemia,Chemotherapy,Chromothripsis,PREDICTIVE,RESISTANCE
TYMS Amplification,Colorectal Cancer,5-Fluorouracil/Salicylic Acid Topical Solution,TYMS,PREDICTIVE,RESISTANCE
FAT1 Loss,Breast Cancer,CDK4/6 Inhibition,FAT1,PREDICTIVE,RESISTANCE
FNTB RS11623866,Ovarian Cancer,Lonafarnib,FNTB,PREDICTIVE,RESISTANCE
PROM1 EXPRESSION,Hepatocellular Carcinoma,Sorafenib,"FGF19,PROM1",PREDICTIVE,RESISTANCE
TIMP1 Overexpression,Breast Cancer,Paclitaxel,"TIMP1,ABCC3,MYD88",PREDICTIVE,RESISTANCE
TYMS Overexpression,Gastric Adenocarcinoma,Raltitrexed,TYMS,PREDICTIVE,RESISTANCE
CXCR4 EXPRESSION,Gastric Adenocarcinoma,Docetaxel,CXCR4,PREDICTIVE,RESISTANCE
FLT3 ITD,Acute Myeloid Leukemia,Selumetinib,FLT3,PREDICTIVE,RESISTANCE
CDKN2A p16 Expression,Head And Neck Squamous Cell Carcinoma,Afatinib,CDKN2A,PREDICTIVE,RESISTANCE
MLH1 METHYLATION,Stomach Carcinoma,Oxaliplatin,MLH1,PREDICTIVE,RESISTANCE
PTEN Loss,Stomach Carcinoma,Chemotherapy,PTEN,PREDICTIVE,RESISTANCE
NRAS G13V,Head And Neck Squamous Cell Carcinoma,Cetuximab,"NRAS,CDKN2A,EGFR,SMAD4,AREG,EGF",PREDICTIVE,RESISTANCE
EGFR Exon 20 Insertion,Lung Adenocarcinoma,Erlotinib,"EGFR,ERBB2,PIK3CA,MET,KRAS,FGFR4",PREDICTIVE,RESISTANCE
KIT D816V,Systemic Mastocytosis,Imatinib Mesylate,KIT,PREDICTIVE,RESISTANCE
HRAS G12D,Skin Squamous Cell Carcinoma,Vemurafenib,"HRAS,TP53,KRAS",PREDICTIVE,RESISTANCE
KRAS G12A,Colon Cancer,Cetuximab,KRAS,PREDICTIVE,RESISTANCE
KRAS G12D,Colorectal Cancer,Regorafenib,"PIK3CA,KRAS,FBXW7",PREDICTIVE,RESISTANCE
KIT Exon 11 Mutation,Melanoma,Dasatinib,"KIT,BRAF",PREDICTIVE,RESISTANCE
JAK1 Q503*,Skin Melanoma,Pembrolizumab,"JAK2,JAK1,B2M",PREDICTIVE,RESISTANCE
MET D1228V,Lung Non-small Cell Carcinoma,Savolitinib,MET,PREDICTIVE,RESISTANCE
JAK1 P429S,Melanoma,Pembrolizumab,"JAK2,JAK1,B2M",PREDICTIVE,RESISTANCE
JAK1 W690*,Colon Carcinoma,Pembrolizumab,JAK1,PREDICTIVE,RESISTANCE
SMO D473H,Medulloblastoma,Vismodegib,SMO,PREDICTIVE,RESISTANCE
HAVCR2 Overexpression,Lung Non-small Cell Carcinoma,PD1 Inhibitor,HAVCR2,PREDICTIVE,RESISTANCE
ALK F1245C,Neuroblastoma,Crizotinib,ALK,PREDICTIVE,RESISTANCE
HLA-C COPY-NEUTRAL LOSS OF HETEROZYGOSITY,Colorectal Cancer,Therapeutic Tumor Infiltrating Lymphocytes,HLA-C,PREDICTIVE,RESISTANCE
KIT D820Y,Melanoma,Imatinib,"KIT,PDGFRA",PREDICTIVE,RESISTANCE
FGFR3 V555L,Transitional Cell Carcinoma,Infigratinib,FGFR3,PREDICTIVE,RESISTANCE
FLT3 ITD N676K,Acute Myeloid Leukemia,Midostaurin,FLT3,PREDICTIVE,RESISTANCE
ROS1 D2033N,Lung Cancer,Crizotinib,ROS1,PREDICTIVE,RESISTANCE
MAP2K1 K57N,Melanoma,Selumetinib,"ERBB3,MAP2K1,MET,DDX43,MITF",PREDICTIVE,RESISTANCE
PTEN Loss,Uterus Leiomyosarcoma,Pembrolizumab,PTEN,PREDICTIVE,RESISTANCE
KRAS G12D,Lung Non-small Cell Carcinoma,Dabrafenib,KRAS,PREDICTIVE,RESISTANCE
BRAF V600,Melanoma,Refametinib,BRAF,PREDICTIVE,RESISTANCE
KRAS Q22*,Colon Mucinous Adenocarcinoma,Panitumumab,KRAS,PREDICTIVE,RESISTANCE
KRAS G12D,Hairy Cell Leukemia,Vemurafenib,KRAS,PREDICTIVE,RESISTANCE
EGFR Exon 20 Insertion,Lung Adenocarcinoma,Gefitinib,"EGFR,ERBB2,PIK3CA,MET,KRAS",PREDICTIVE,RESISTANCE
AR AR-V7,Salivary Gland Cancer,Abiraterone Acetate,AR,PREDICTIVE,RESISTANCE
MAP2K2 H123Q,Pancreatic Cancer,Trametinib,"ETV5,ETV1,ATXN1L,ETV4,CIC,MAP2K2",PREDICTIVE,RESISTANCE
MAP2K2 G132D,Pancreatic Adenocarcinoma,Trametinib,"KRAS,MAP2K2",PREDICTIVE,RESISTANCE
BCL2 F104I,Follicular Lymphoma,Venetoclax,BCL2,PREDICTIVE,RESISTANCE
NTRK3 F617L,Gastrointestinal Stromal Tumor,Larotrectinib,NTRK3,PREDICTIVE,RESISTANCE
IRS2 Amplification,Prostate Cancer,Capivasertib,IRS2,PREDICTIVE,RESISTANCE
EGFR EGFRVIII,Colon Adenocarcinoma,Erlotinib,EGFR,PREDICTIVE,RESISTANCE
ATM R2459C,Chronic Lymphocytic Leukemia,Doxorubicin,ATM,PREDICTIVE,RESISTANCE
RET C634W,Medullary Thyroid Carcinoma,Axitinib,RET,PREDICTIVE,RESISTANCE
HRAS G12D,Head And Neck Cancer,Erlotinib,HRAS,PREDICTIVE,RESISTANCE
KRAS G12A,Colorectal Cancer,Sunitinib,KRAS,PREDICTIVE,RESISTANCE
NRAS Q61R,Thyroid Gland Carcinoma,Vemurafenib,"NRAS,HRAS,KRAS",PREDICTIVE,RESISTANCE
KRAS Q61H,Lung Non-small Cell Carcinoma,Vemurafenib,"BRAF,KRAS",PREDICTIVE,RESISTANCE
KRAS G12D,Pancreatic Cancer,Vemurafenib,"BRAF,KRAS",PREDICTIVE,RESISTANCE
KRAS G12S,Lung Squamous Cell Carcinoma,Dasatinib,KRAS,PREDICTIVE,RESISTANCE
KIT V654A,Gastrointestinal Stromal Tumor,Regorafenib,"KIT,BRAF",PREDICTIVE,RESISTANCE
KRAS K117N,Clear Cell Sarcoma,Vemurafenib,KRAS,PREDICTIVE,RESISTANCE
BRAF F595L,Histiocytoma,Vemurafenib,BRAF,PREDICTIVE,RESISTANCE
KIT T670I,Solid Tumor,Dasatinib,KIT,PREDICTIVE,RESISTANCE
EGFR Y69FS*11,Esophagus Squamous Cell Carcinoma,Erlotinib,EGFR,PREDICTIVE,RESISTANCE
ERBB4 G1109C,Head And Neck Squamous Cell Carcinoma,Erlotinib,ERBB4,PREDICTIVE,RESISTANCE
ERBB2 L755S,Breast Cancer,Lapatinib,"NRG1,ERBB2,PIK3CA,PTEN,CDKN1B,ERBB4",PREDICTIVE,RESISTANCE
FLT3 F691L,Acute Myeloid Leukemia,Crenolanib,FLT3,PREDICTIVE,RESISTANCE
AR W742,Prostate Carcinoma,Bicalutamide,AR,PREDICTIVE,RESISTANCE
BIRC7 Amplification,Colon Cancer,Cisplatin,BIRC7,PREDICTIVE,RESISTANCE
EGFR Exon 4 Deletion,Epithelial Ovarian Cancer,Cisplatin,EGFR,PREDICTIVE,RESISTANCE
MAPK1 Amplification,Lung Non-small Cell Carcinoma,WZ4002,MAPK1,PREDICTIVE,RESISTANCE
AKT3 Overexpression,Breast Cancer,Akt Inhibitor MK2206,AKT3,PREDICTIVE,RESISTANCE
KRAS G13D,Breast Cancer,Pictilisib,KRAS,PREDICTIVE,RESISTANCE
EGFR T790M,Lung Non-small Cell Carcinoma,Lapatinib,EGFR,PREDICTIVE,RESISTANCE
TP53 Deleterious Mutation,Cancer,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 Deleterious Mutation,Cancer,Rebemadlin,TP53,PREDICTIVE,RESISTANCE
CDKN2A p16 Expression,Sarcoma,Palbociclib,"CDKN2A,CDK4",PREDICTIVE,RESISTANCE
KRAS G12S,Lung Non-small Cell Carcinoma,MUC1-targeted Peptide GO-203-2C,KRAS,PREDICTIVE,RESISTANCE
RAC1 P29S,Skin Melanoma,PLX4720,"GNAQ,RAC1",PREDICTIVE,RESISTANCE
ZEB1 Expression,Colon Cancer,Oxaliplatin,"ZEB1,POU5F1",PREDICTIVE,RESISTANCE
PTEN Loss,Her2-receptor Positive Breast Cancer,Lapatinib,"PIK3CA,PTEN",PREDICTIVE,RESISTANCE
FLT3 ITD & D835(V/Y/F/H),Acute Myeloid Leukemia,Ponatinib,FLT3,PREDICTIVE,RESISTANCE
ACTL6A Overexpression,Lung Adenocarcinoma,Cisplatin,ACTL6A,PREDICTIVE,RESISTANCE
CD44 CD44v6,Stomach Cancer,Cisplatin,CD44,PREDICTIVE,RESISTANCE
TNC TNC-L,Pancreatic Cancer,Gemcitabine,"RRM2,KRAS,RRM1,TNC",PREDICTIVE,RESISTANCE
TOP2A TOP2A/90,Leukemia,Etoposide,TOP2A,PREDICTIVE,RESISTANCE
TP53 R158L,Colorectal Adenocarcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R273C,Ewing Sarcoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R273C,Malignant Astrocytoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R175H,Pharynx Squamous Cell Carcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R175H,Intrahepatic Cholangiocarcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R175H,Endometrial Adenocarcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
OVOL2 Overexpression,Glandular Pattern Ovarian Yolk Sac Tumor,Cisplatin,OVOL2,PREDICTIVE,RESISTANCE
ALK F1174L,Inflammatory Myofibroblastic Tumor,Crizotinib,ALK,PREDICTIVE,RESISTANCE
ALK R1275Q,Neuroblastoma,ALK Inhibitor TAE684,ALK,PREDICTIVE,RESISTANCE
RET C634W,Medullary Thyroid Carcinoma,Motesanib,RET,PREDICTIVE,RESISTANCE
FLT3 ITD,Acute Myeloid Leukemia,Daunorubicin,"DNMT3A,WT1,FLT3",PREDICTIVE,RESISTANCE
FLT3 ITD,Acute Myeloid Leukemia,SU5614,FLT3,PREDICTIVE,RESISTANCE
ESR1 L536Q,Breast Cancer,Hormone Therapy,ESR1,PREDICTIVE,RESISTANCE
AURKA Overexpression,Cervical Adenocarcinoma,Paclitaxel,AURKA,PREDICTIVE,RESISTANCE
LRP1B EXON 12-22 DELETION,Ovarian Cancer,Doxorubicin,"LRP1B,TP53",PREDICTIVE,RESISTANCE
SYK OVEREXPRESSION,Ovarian Cancer,Paclitaxel,"SYK,TP53,KRAS",PREDICTIVE,RESISTANCE
UGT1A EXPRESSION,Colorectal Cancer,Ganetespib,UGT1A,PREDICTIVE,RESISTANCE
CFLAR EXPRESSION,Prostate Cancer,Bicalutamide,"AR,CFLAR",PREDICTIVE,RESISTANCE
ABCC10 Overexpression,Lung Non-small Cell Carcinoma,Paclitaxel,"ABCB1,ABCC10",PREDICTIVE,RESISTANCE
FGFR1 Amplification,Breast Cancer,Afimoxifene,FGFR1,PREDICTIVE,RESISTANCE
TP53 Loss,Lung Non-small Cell Carcinoma,Docetaxel,"TP53,KRAS,STK11",PREDICTIVE,RESISTANCE
PTEN Mutation,Head And Neck Squamous Cell Carcinoma,Taselisib,PTEN,PREDICTIVE,RESISTANCE
RB1 Loss-of-function,Glioblastoma,Palbociclib,RB1,PREDICTIVE,RESISTANCE
CCNE1 Amplification,Estrogen-receptor Positive Breast Cancer,Palbociclib,"CCNE1,RB1",PREDICTIVE,RESISTANCE
GAS6 EXPRESSION,Prostate Cancer,Docetaxel,GAS6,PREDICTIVE,RESISTANCE
VPS37A Underexpression,Ovarian Cancer,Cetuximab,"VPS37A,KRAS",PREDICTIVE,RESISTANCE
AKT3 Overexpression,Breast Cancer,Pan-AKT Kinase Inhibitor GSK690693,AKT3,PREDICTIVE,RESISTANCE
FLT3 D835V,Acute Myeloid Leukemia,Tandutinib,FLT3,PREDICTIVE,RESISTANCE
ERBB2 L755S,Cecum Adenocarcinoma,Cetuximab,ERBB2,PREDICTIVE,RESISTANCE
TP53 M237I,Glioblastoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
TP53 R158H,Vulva Squamous Cell Carcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
CIC Loss,Lung Cancer,Trametinib,"ETV5,ETV1,ETV4,CIC",PREDICTIVE,RESISTANCE
CIC Loss,Lung Cancer,Vemurafenib,CIC,PREDICTIVE,RESISTANCE
CIC Loss,Colon Cancer,Trametinib,CIC,PREDICTIVE,RESISTANCE
CIC Loss,Colon Cancer,Vemurafenib,CIC,PREDICTIVE,RESISTANCE
CIC Loss,Pancreatic Cancer,Selumetinib,CIC,PREDICTIVE,RESISTANCE
CIC Loss,Lung Cancer,Selumetinib,CIC,PREDICTIVE,RESISTANCE
SUFU Deletion,Medulloblastoma,Sonidegib,"MYCN,SUFU",PREDICTIVE,RESISTANCE
EGFR V774_C775insHV,Cancer,Erlotinib,"HRAS,KRAS,VEGFA,EGFR",PREDICTIVE,RESISTANCE
BRAF D594G,Skin Melanoma,U0126,BRAF,PREDICTIVE,RESISTANCE
RHEB Y35N,Kidney Cancer,Sirolimus,RHEB,PREDICTIVE,RESISTANCE
KIT D816H,Acute Myeloid Leukemia,Imatinib Mesylate,KIT,PREDICTIVE,RESISTANCE
KRAS G13D,Colorectal Cancer,Dual IGF-1R/InsR Inhibitor BMS-754807,"BRAF,KRAS",PREDICTIVE,RESISTANCE
BRAF L525R,Solid Tumor,Cetuximab,BRAF,PREDICTIVE,RESISTANCE
CCNE1 Overexpression,Ovarian Cancer,Palbociclib,CCNE1,PREDICTIVE,RESISTANCE
IL6 Overexpression,Esophageal Carcinoma,Cisplatin,IL6,PREDICTIVE,RESISTANCE
PARP1 OVEREXPRESSION,Breast Cancer,Olaparib,"BRCA1,PARP1",PREDICTIVE,RESISTANCE
FLT3 Y693,Acute Myeloid Leukemia,Gilteritinib,FLT3,PREDICTIVE,RESISTANCE
FLT3 Y842C,Acute Myeloid Leukemia,FLT3/ABL/Aurora Kinase Inhibitor KW-2449,FLT3,PREDICTIVE,RESISTANCE
FLT3 Y842C,Acute Myeloid Leukemia,Sunitinib,FLT3,PREDICTIVE,RESISTANCE
FLT3 F691L,Acute Myeloid Leukemia,Lestaurtinib,FLT3,PREDICTIVE,RESISTANCE
CREBBP Mutation,Acute Lymphoblastic Leukemia,Therapeutic Glucocorticoid,CREBBP,PREDICTIVE,RESISTANCE
FGFR3 S249C,Transitional Cell Carcinoma,Cisplatin,FGFR3,PREDICTIVE,RESISTANCE
FLT3 M664I,Acute Myeloid Leukemia,Pexidartinib,FLT3,PREDICTIVE,RESISTANCE
BRAF V600E,Diffuse Large B-cell Lymphoma,Venetoclax,BRAF,PREDICTIVE,RESISTANCE
ACTL6A Overexpression,Ovarian Cancer,Cisplatin,"ASS1,TP53,EGFR,ACTL6A,STAT1,ATP7B,CD44,PTEN",PREDICTIVE,RESISTANCE
PIM1 L2V,Diffuse Large B-cell Lymphoma Activated B-cell Type,Ibrutinib,PIM1,PREDICTIVE,RESISTANCE
TP53 R280T,Bladder Carcinoma,MDM2 Inhibitor AMGMDS3,TP53,PREDICTIVE,RESISTANCE
FGFR3 N540D,Multiple Myeloma,Midostaurin,FGFR3,PREDICTIVE,RESISTANCE
ERBB2 V777L,Cancer,Trastuzumab,"ERBB3,ERBB2,PIK3CA,PTEN,BIRC5,ERBB4",PREDICTIVE,RESISTANCE
EGFR D770_P772dup,Cancer,Gefitinib,"ERBB3,KRAS,EGFR",PREDICTIVE,RESISTANCE
CBLC EXPRESSION,Cancer,Olaparib,"BRCA1,PARP1,CBLC",PREDICTIVE,RESISTANCE
TUBB3 EXPRESSION,Cancer,Paclitaxel,"TIMP1,TP53,TUBB3,SYK,ABCC3,KRAS,MYD88",PREDICTIVE,RESISTANCE
NQO1 EXPRESSION,Lung Cancer,Amrubicin,NQO1,PREDICTIVE,RESISTANCE
MAGEH1 EXPRESSION,Bile Duct Adenocarcinoma,Gemcitabine,MAGEH1,PREDICTIVE,RESISTANCE
ASNS Amplification,Ovarian Cancer,Asparaginase,ASNS,PREDICTIVE,RESISTANCE
ESR1 S463P,Estrogen-receptor Positive Breast Cancer,Aromatase Inhibitor,ESR1,PREDICTIVE,RESISTANCE
ERBB2 L755S,Cancer,Lapatinib,"NRG1,ERBB2,PIK3CA,PTEN,CDKN1B,ERBB4",PREDICTIVE,RESISTANCE
PDGFRA D842V,Cancer,Sunitinib,"KIT,PDGFRA,KRAS",PREDICTIVE,RESISTANCE
PDGFRA D842V,Cancer,Imatinib Mesylate,PDGFRA,PREDICTIVE,RESISTANCE
KRAS G12,Pancreatic Cancer,Mitogen-Activated Protein Kinase Kinase Inhibitor,KRAS,PREDICTIVE,RESISTANCE
IL6 Overexpression,Rhabdomyosarcoma,Bazedoxifene,IL6,PREDICTIVE,RESISTANCE
PTEN Loss,Her2-receptor Positive Breast Cancer,Dactolisib,"PIK3CA,PTEN",PREDICTIVE,RESISTANCE
KIT Overexpression,Gastrointestinal System Cancer,Imatinib,KIT,PREDICTIVE,RESISTANCE
PTEN Loss,Stomach Cancer,Docetaxel,PTEN,PREDICTIVE,RESISTANCE
IFNGR1 Loss,Melanoma,Ipilimumab,IFNGR1,PREDICTIVE,RESISTANCE
B2M Loss,Melanoma,Immune Checkpoint Inhibitor,B2M,PREDICTIVE,RESISTANCE
EGFR D770_P772dup,Cancer,Afatinib,"ERBB2,EGFR",PREDICTIVE,RESISTANCE
PIK3CA Mutation,Colorectal Cancer,PD-1 Ligand Inhibitor,PIK3CA,PREDICTIVE,RESISTANCE
BAX mutation,Acute Myeloid Leukemia,Venetoclax,BAX,PREDICTIVE,RESISTANCE
KRAS Mutation,Colorectal Cancer,Ixazomib,KRAS,PREDICTIVE,RESISTANCE
SIRT1 Overexpression,Pancreatic Cancer,Niacinamide,SIRT1,PREDICTIVE,RESISTANCE
ROS1 Overexpression,Glioblastoma,Gefitinib,ROS1,PREDICTIVE,RESISTANCE
PIK3CA E542K,Breast Cancer,PI-103,PIK3CA,PREDICTIVE,RESISTANCE
PTEN Loss,Breast Cancer,PI3Ka/Di,PTEN,PREDICTIVE,RESISTANCE
PTEN Loss,Her2-receptor Positive Breast Cancer,PI3Ka/Di,PTEN,PREDICTIVE,RESISTANCE
HRAS G12V,Head And Neck Squamous Cell Carcinoma,Alpelisib,HRAS,PREDICTIVE,RESISTANCE
AR V9 EXPRESSION,Prostate Cancer,Abiraterone Acetate,AR,PREDICTIVE,RESISTANCE
ZEB1 Increased Expression,Cancer,Chemotherapy,"NRAS,ZEB1,PIK3CA,BRAF,KRAS",PREDICTIVE,RESISTANCE
TP53 P47S,Cancer,Cisplatin,"ASS1,TP53,EGFR,GNAS,BIRC7,ACTL6A,PIK3CA,STAT1,ATP7B,CD44,PTEN",PREDICTIVE,RESISTANCE
